Cytosorbents Corporation

1.00
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
1.00
0.00%
After-hours: Apr 01, 2025, 04:40 PM EDT

Cytosorbents Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 3.28M 14.13M 22.14M 52.14M 71.42M
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a 1.73M 1.94M 125.89K
Other Long-Term Assets 5.25M 1.54M 1.73M 1.94M 4.35M
Receivables 7.32M 6.06M 5.66M 4.52M 5.16M
Inventory 2.73M 3.68M 3.46M 4.77M 2.67M
Other Current Assets 8.27M 1.83M 2.49M n/a n/a
Total Current Assets 21.6M 25.7M 33.76M 64.3M 82.45M
Property-Plant & Equipment 20.51M 22.12M 23.35M 18.57M 3.15M
Goodwill & Intangibles n/a 3.91M 4.39M 4.7M 4.22M
Total Long-Term Assets 25.77M 27.56M 29.47M 25.22M 7.5M
Total Assets 47.37M 53.26M 63.23M 89.52M 89.95M
Account Payables 3.34M 3.8M 1.66M 2.81M 1.84M
Deferred Revenue n/a 1.38M 1.68M 2.16M 1.03M
Short-Term Debt 452.69K 2.5M n/a n/a n/a
Other Current Liabilities 6.03M 3.09M 5.09M 7.04M 4.71M
Total Current Liabilities 9.82M 14.55M 9.71M 13.69M 10.15M
Long-Term Debt 12.44M 2.54M 5M n/a n/a
Other Long-Term Liabilities 14M n/a n/a n/a n/a
Total Long-Term Liabilities 26.44M 15.44M 18.14M 13.25M 582K
Total Liabilities 36.26M 29.99M 27.86M 26.94M 10.73M
Total Debt 12.9M 18.31M 18.25M 13.82M 1.03M
Common Stock 54.83K 54.24K 43.63K 43.48K 43.22K
Retained Earnings -304.01M -282.51M -254M -221.19M -196.63M
Comprehensive Income 4.25M 529.32K 2.33M 525.59K -1.73M
Shareholders Equity 11.11M 23.28M 35.38M 62.58M 79.22M
Total Investments n/a 1.48M 1.73M 1.94M 125.89K